Why the study?
Does elevated baseline copeptin predict the development of metabolic syndrome, diabetes mellitus, abdominal obesity, and microalbuminuria in a general population cohort?
Population
2,064 subjects from the population-based Malmö Diet and Cancer Study cardiovascular cohort, mean age 57.0…
Comparison
Baseline plasma copeptin levels vs Lowest quartile of baseline plasma copeptin
Design
Cohort
Follow-up
mean 15.8 years
Authors
Loading...
Elevated copeptin may flag future cardiometabolic risk beyond baseline components; extends observational data but leaves clinical utility and causality open.
Does elevated baseline copeptin predict the development of metabolic syndrome, diabetes mellitus, abdominal obesity, and microalbuminuria in a general population cohort?
Elevated baseline copeptin independently predicts the long-term development of diabetes mellitus, abdominal obesity, and microalbuminuria, suggesting a role for the vasopressin system in cardiometabolic risk.
Enhörning et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: